Angiogenic Precursor Cell Treatment of Critical Limb Ischemia Decreases Ulcer Size, Amputation and Death Rate: Re-Examination of phase II ACP NO-CLI Trial Data
Crossref DOI link: https://doi.org/10.37871/jbres1876
Published Online: 2024-02
Update policy: https://doi.org/10.37871/jbres.policy
Henderson, Fraser C
Sarel, Ina
Tuchman, Kelly
Lewis, Stephen
Hsiang, York